Competitively inhibit the adsorption of plasminogen on fibrin, prevent its activation, protect fibrin from being degraded and dissolved by plasmin, and achieve hemostatic effect; directly inhibit plasmin activity, reduce the effect of plasmin activating complement, and prevent the occurrence of hereditary angioedema.

Competitively inhibit the adsorption of plasminogen on fibrin, prevent its activation, protect fibrin from being degraded and dissolved by plasmin, and achieve hemostatic effect; directly inhibit plasmin activity, reduce the effect of plasmin activating complement, and prevent the occurrence of hereditary angioedema.

It competitively inhibits the adsorption of plasminogen on fibrin, prevents its activation, and protects fibrin from being degraded and dissolved by plasmin, thereby achieving a hemostatic effect. It can also directly inhibit the activity of plasmin, reduce the effect of plasmin in activating complement, and prevent the occurrence of hereditary angioedema.

Coenzyme drugs are nucleotide derivatives that participate in the synthesis and metabolism of phospholipids and nucleic acids in the body. They are intermediate products and energy sources for brain phospholipid synthesis and nucleic acid metabolism.

Methylcobalamin is an endogenous coenzyme B12 that plays an important role as a coenzyme of methionine synthase in the transmethylation reaction of methionine synthesized from homocysteine. It is easily transferred to the organelles of nerve cells, thereby promoting the synthesis of nucleic acids and proteins. It promotes axonal transport and axonal regeneration. It is effective against sciatica neuropathy in diabetic rats caused by streptozotocin.